𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Antibodies to recombinant HIV-1 vif, tat, and nef proteins in human sera

✍ Scribed by Ulrike Wieland; Joachim E. Kühn; Christian Jassoy; Helga Rübsamen-Waigmann; Vera Wolber; Rüdiger W. Braun

Publisher
Springer-Verlag
Year
1990
Tongue
English
Weight
847 KB
Volume
179
Category
Article
ISSN
0300-8584

No coin nor oath required. For personal study only.

✦ Synopsis

The prevalence of antibodies against HIV-1 regulatory proteins in sera of HIV-infected patients from different stages of disease was investigated. HIV-1 vif, tat, and nef genes were cloned in procaryotic vectors and were expressed as MS-2 fusion proteins (vif and nef) or as a non-fusion protein (tat). These recombinant proteins were employed in immunoblot experiments. The specifity of the recognition was confirmed by competition experiments and with control sera from HIV-negative patients. Analysis of 136 serum samples revealed a high percentage of antibodies against nef, irrespective of the stage of disease. Antibodies against tat were found less frequently and increased from 16 % to 40 % with disease progression. Vif antibodies were detected only in a low percentage in early stages of disease, but their prevalence increased to 36 % and 72% with progression of disease to AIDS-related complex and AIDS. Our data suggest that the detection of antibodies against nef may represent an additional and useful marker for the diagnosis of HIV infection, whereas the detection of vif antibodies may indicate disease progression.

📜 SIMILAR VOLUMES

Natural antibodies to HIV-tat epitopes a
Natural antibodies to HIV-tat epitopes and expression of HIV-1 genes in vivo
✍ Willy J. A. Krone; Christine Debouck; Leon G. Epstein; Peter Heutink; Rob Meloen 📂 Article 📅 1988 🏛 John Wiley and Sons 🌐 English ⚖ 628 KB

The tat regulatory protein of HIV-1 was expressed as a fusion protein in E. coli and used as antigen to detect antibodies against HIV-tat (anti-tat) in the serum of HIV-1 infected children and adults. HIV-1-infected children showed a higher frequency (55%) of anti-tat than HIV-1-infected adults (36%

Bifunctional recombinant fusion proteins
Bifunctional recombinant fusion proteins for rapid detection of antibodies to both HIV-1 and HIV-2 in whole blood
✍ Amita Gupta; Vijay K Chaudhary 📂 Article 📅 2006 🏛 BioMed Central 🌐 English ⚖ 793 KB

## Background Availability of accurate diagnostic tests has been helpful in curtailing the spread of HIV infection. Among these, simple, point of care, inexpensive tests which require only a drop of blood from finger-prick and give reliable results within minutes are a must for expansion of testing

Prevalence of antibodies to recombinant
Prevalence of antibodies to recombinant virion infectivity factor in the sera of prospectively studied patients with HIV-1 infection
✍ S. Schwander; R. W. Braun; J. E. Kühn; F. T. Hufert; P. Kern; M. Dietrich; U. Wi 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 579 KB

## Abstract Two hundred twenty‐four sera were collected from 34 HIV‐1 infected patients during an observation period of up to 4.5 years (109 patient years of observation). The sera were tested for the presence of antibodies against the HIV‐1 virion infectivity factor (vif) protein. Thirty sera from

Association of antibodies blocking HIV-1
Association of antibodies blocking HIV-1 gp160-sCD4 attachment with virus neutralizing activity in human sera
✍ Nicole K. T. Back; Clotilde Thiriart; Anne Delers; Chitra Ramautarsing; Claudine 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 955 KB

## Abstract Sera, from HIV‐1 and HIV‐2 seropositive individuals, were tested for the presence of antibodies able to inhibit the binding (BI) of HIV‐IIIB gp160 (produced in mammalian cells using a vaccinia expression system) to the extracellular portion of the CD4 receptor. A competition enzyme immu